Sign Up Today and Learn More About NextPoint Therapeutics Stock
Invest in or calculate the value of your shares in NextPoint Therapeutics or other pre-IPO companies through EquityZen's platform.
![NextPoint Therapeutics](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/nextpointtherapeutics_logo-07f3a40ae0bf996b.jpg)
NextPoint Therapeutics Stock
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients.
About NextPoint Therapeutics Stock
Founded
2020
Headquarters
Cambridge, MA, US
Industries
NextPoint Therapeutics Press Mentions
Stay in the know about the latest news on NextPoint Therapeutics
NextPoint Therapeutics, Inc. on LinkedIn: #time100health
linkedin • Jul 05, 2024
TIME reveals new list recognizing the 100 most influential individuals in health
news-medical • Jun 05, 2024
USFDA accepts NextPoint Therapeutics's IND for NPX887
pharmaceutical-business-review • Jun 05, 2024
Nextpoint Therapeutics’ antibodies enhance antitumor immune responses
bioworld • May 20, 2024
NextPoint Therapeutics Chief Executive Officer Ivan Cheung Named to the 2024 TIME100 Health List
businesswire • May 19, 2024
NextPoint Therapeutics Management
Leadership team at NextPoint Therapeutics
Scientific Co-Founder
Xingxing Zang
Scientific Co-Founder
Gordon Freeman
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- NextPoint Therapeutics current valuation
- NextPoint Therapeutics stock price
- Available deals in NextPoint Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in NextPoint Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like NextPoint Therapeutics through EquityZen funds. These investments are made available by existing NextPoint Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NextPoint Therapeutics stock?
Shareholders can sell their NextPoint Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."